Aquestive Therapeutics Inc (AQST) Stock Price and Analyst Predictions
The stock has a 36-month beta value of 2.85. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 1 as
The stock has a 36-month beta value of 2.85. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 1 as
Aquestive Therapeutics Inc (NASDAQ: AQST) has experienced a decline in its stock price by -6.62 compared to its previous closing price of 4.38. However, the
The stock has a 36-month beta value of 2.85. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 1 as
The stock price of Aquestive Therapeutics Inc (NASDAQ: AQST) has dropped by -14.08 compared to previous close of 5.68. Despite this, the company has seen
The stock price of Aquestive Therapeutics Inc (NASDAQ: AQST) has jumped by 15.53 compared to previous close of 3.67. Despite this, the company has seen
In the past week, AQST stock has gone up by 5.75%, with a monthly gain of 20.25% and a quarterly surge of 39.71%. The volatility
The 36-month beta value for AQST is also noteworthy at 2.74. The public float for AQST is 62.96M, and at present, short sellers hold a
The stock of Aquestive Therapeutics Inc (AQST) has gone up by 0.37% for the week, with a -1.47% drop in the past month and a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.